献血者发生脑出血与其受血者发生脑出血的关联
该探索性回顾性队列研究利用瑞典(主队列)和丹麦(验证队列)全国血库与健康登记数据,纳入1970年1月1日(瑞典)或1980年1月1日(丹麦)至2017年12月31日期间接受红细胞输注的5至80岁患者共1 089 370例。暴露为接受日后发生单次自发性脑出血、多次自发性脑出血或未发生自发性脑出血的献血者的红细胞。主要结局为受血者发生自发性脑出血,缺血性卒中为阴性对照结局。结果显示,接受日后发生多次自发性脑出血献血者红细胞的患者,自身发生自发性脑出血的风险显著升高(瑞典调整HR 2.73,95%CI 1.72-4.35,P<.001;丹麦调整HR 2.32,95%CI 1.04-5.19,P=.04);接受日后发生单次自发性脑出血献血者红细胞的患者无显著差异。作者认为这可能提示与某些类型自发性脑出血相关的输血传播因子,但结果可能受选择偏倚和残余混杂影响,需进一步研究。
要点
- 接受日后发生多次自发性脑出血献血者红细胞的患者,自身自发性脑出血风险显著升高:瑞典调整HR 2.73(95%CI 1.72-4.35,P<.001)。
- 丹麦验证队列结果一致:接受日后发生多次自发性脑出血献血者红细胞的患者,调整HR 2.32(95%CI 1.04-5.19,P=.04)。
- 接受日后发生单次自发性脑出血献血者红细胞的患者,自发性脑出血风险无显著差异:瑞典调整HR 1.06(95%CI 0.84-1.36,P=.62),丹麦调整HR 1.06(95%CI 0.70-1.60,P=.73)。
- 缺血性卒中作为阴性对照结局,未发现显著差异。
- 作者认为这可能提示与某些类型自发性脑出血相关的输血传播因子,但结果可能受选择偏倚和残余混杂影响,需进一步研究。
适用人群与场景
- 瑞典(主队列)和丹麦(验证队列)全国范围内,1970年1月1日(瑞典)或1980年1月1日(丹麦)至2017年12月31日期间记录接受红细胞输注的5至80岁患者,共1 089 370例。
研究设计与关键结果
- 探索性回顾性队列研究,使用瑞典和丹麦全国血库与健康登记数据,纳入1 089 370例接受红细胞输注的患者(瑞典759 858例,中位年龄65岁[IQR 48-73],女性59%;丹麦329 512例,中位年龄64岁[IQR 50-73],女性58%)。
- 瑞典队列中位随访5.8年(IQR 1.4-12.5),丹麦队列中位随访6.1年(IQR 1.5-11.6)。
- 接受日后发生多次自发性脑出血献血者红细胞的患者,自身发生自发性脑出血的风险显著升高:瑞典未调整发生率3.16 vs 1.12/1000人年,调整HR 2.73(95%CI 1.72-4.35,P<.001);丹麦未调整发生率2.82 vs 1.09/1000人年,调整HR 2.32(95%CI 1.04-5.19,P=.04)。
- 接受日后发生单次自发性脑出血献血者红细胞的患者,自身发生自发性脑出血的风险无显著差异:瑞典未调整发生率1.35 vs 1.12/1000人年,调整HR 1.06(95%CI 0.84-1.36,P=.62);丹麦未调整发生率1.36 vs 1.09/1000人年,调整HR 1.06(95%CI 0.70-1.60,P=.73)。
- 缺血性卒中作为阴性对照结局,未发现显著差异。
证据类型、等级与局限
- 证据类型:探索性回顾性队列研究。
- 局限:原文指出结果可能受选择偏倚和残余混杂影响;需进一步研究以探讨脑淀粉样血管病的输血传播是否能解释该关联。
对床旁实践的改变
- 作者认为,接受日后发生多次自发性脑出血献血者红细胞的患者,自身发生自发性脑出血的风险显著升高,这可能提示与某些类型自发性脑出血相关的输血传播因子;但结果可能受选择偏倚和残余混杂影响,需进一步研究。
- 原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Recent reports have suggested that cerebral amyloid angiopathy, a common cause of multiple spontaneous intracerebral hemorrhages (ICHs), may be transmissible through parenteral injection of contaminated cadaveric pituitary hormone in humans.
OBJECTIVE: To determine whether spontaneous ICH in blood donors after blood donation is associated with development of spontaneous ICH in transfusion recipients.
DESIGN, SETTING, AND PARTICIPANTS: Exploratory retrospective cohort study using nationwide blood bank and health register data from Sweden (main cohort) and Denmark (validation cohort) and including all 1 089 370 patients aged 5 to 80 years recorded to have received a red blood cell transfusion from January 1, 1970 (Sweden), or January 1, 1980 (Denmark), until December 31, 2017.
EXPOSURES: Receipt of red blood cell transfusions from blood donors who subsequently developed (1) a single spontaneous ICH, (2) multiple spontaneous ICHs, or (3) no spontaneous ICH.
MAIN OUTCOMES AND MEASURES: Spontaneous ICH in transfusion recipients; ischemic stroke was a negative control outcome.
RESULTS: A total of 759 858 patients from Sweden (median age, 65 [IQR, 48-73] years; 59% female) and 329 512 from Denmark (median age, 64 [IQR, 50-73] years; 58% female) were included, with a median follow-up of 5.8 (IQR, 1.4-12.5) years and 6.1 (IQR, 1.5-11.6) years, respectively. Patients who underwent transfusion with red blood cell units from donors who developed multiple spontaneous ICHs had a significantly higher risk of a single spontaneous ICH themselves, compared with patients receiving transfusions from donors who did not develop spontaneous ICH, in both the Swedish cohort (unadjusted incidence rate [IR], 3.16 vs 1.12 per 1000 person-years; adjusted hazard ratio [HR], 2.73; 95% CI, 1.72-4.35; P < .001) and the Danish cohort (unadjusted IR, 2.82 vs 1.09 per 1000 person-years; adjusted HR, 2.32; 95% CI, 1.04-5.19; P = .04). No significant difference was found for patients receiving transfusions from donors who developed a single spontaneous ICH in the Swedish cohort (unadjusted IR, 1.35 vs 1.12 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.84-1.36; P = .62) nor the Danish cohort (unadjusted IR, 1.36 vs 1.09 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.70-1.60; P = .73), nor for ischemic stroke as a negative control outcome.
CONCLUSIONS AND RELEVANCE: In an exploratory analysis of patients who received red blood cell transfusions, patients who underwent transfusion with red blood cells from donors who later developed multiple spontaneous ICHs were at significantly increased risk of spontaneous ICH themselves. This may suggest a transfusion-transmissible agent associated with some types of spontaneous ICH, although the findings may be susceptible to selection bias and residual confounding, and further research is needed to investigate if transfusion transmission of cerebral amyloid angiopathy might explain this association.
参考来源
- Zhao J, Rostgaard K, Lauwers E, et al. Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients. JAMA. 2023. PMID: 37698562. doi:10.1001/jama.2023.14445
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。